Anti-TNF and immunosuppressive combination therapy is preferential to inducing clinical remission in patients with active inflammatory bowel disease: A systemic review and meta-analysis,Journal of Digestive Diseases

当前位置： X-MOL 学术 › J. Dig. Dis. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Anti-TNF and immunosuppressive combination therapy is preferential to inducing clinical remission in patients with active inflammatory bowel disease: A systemic review and meta-analysis
Journal of Digestive Diseases ( IF 2.3 ) Pub Date : 2021-05-28 , DOI: 10.1111/1751-2980.13026
Liang Chen _{1,

2} , Chun Jin Xu ₁ , Wei Wu ₂ , Bai Jing Ding ₃ , Zhan Ju Liu ₂

Affiliation

To compare the efficacy and safety of a combination therapy of biologics and immunosuppressants with biological monotherapy in inflammatory bowel disease (IBD) in a systematic review and meta-analysis.

中文翻译：